Carboplatin Treatment Options in Canada

A collection of 336 research studies where Carboplatin is the interventional treatment. These studies are located in the Canada . Carboplatin is used for conditions such as Non-Small Cell Lung Cancer, Ovarian Cancer and Lung Cancer.

Home

Canada

All Treatments

Carboplatin

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer

NCT00021255

Completed

Primary objective: * Compare disease-free survival in women with human epidermal growth factor receptor 2 (HER2)-neu-expressing node-positive or high-risk node-negative operable breast cancer treated with adjuvant doxorubicin, cyclophosphamide, and docetaxel with or without trastuzumab (Herceptin) vs trastuzumab, docetaxel, and carboplatin. Secondary objective: * Compare overall survival of participants treated with these regimens. * Compare the toxic effects (including cardiac) of these regi... Read More

Gender:

FEMALE

Ages:

Between 18 years and 70 years

Trial Updated:

09/26/2016

Locations: Sanofi-Aventis Administrative Office, Bridgewater, New Jersey +41 locations

Sanofi-Aventis Administrative Office, Bridgewater, New Jersey

Sanofi-Aventis Administrative Office, Buenos Aires, Not set

Sanofi-Aventis Administrative Office, Macquarie Park, Not set

Sanofi-Aventis Administrative Office, Vienna, Not set

Sanofi-Aventis Administrative Office, Diegem, Not set

Sanofi-Aventis Administrative Office, Sarajevo, Not set

Sanofi-Aventis Administrative Office, Sao Paulo, Not set

Sanofi-Aventis Administrative Office, Vazrjdane Region, Not set

Sanofi-Aventis Administrative Office, Québec, Not set

Sanofi-Aventis Administrative Office, Bogota, Not set

Sanofi-Aventis Administrative Office, Zagreb, Not set

Sanofi-Aventis Administrative Office, Praha, Not set

Sanofi-Aventis Administrative Office, Cairo, Not set

Sanofi-Aventis Administrative Office, Tallin, Not set

Sanofi-Aventis Administrative Office, Paris, Not set

Sanofi-Aventis Administrative Office, Frankfurt, Not set

Sanofi-Aventis Administrative Office, Kallithea, Not set

Sanofi-Aventis Administrative Office, Hong Kong, Not set

Sanofi-Aventis Administrative Office, Budapest, Not set

Sanofi-Aventis Administrative Office, Mumbai, Not set

Sanofi-Aventis Administrative Office, Dublin, Not set

Sanofi-Aventis Administrative Office, Natanya, Not set

Sanofi-Aventis Administrative Office, Milan, Not set

Sanofi-Aventis Administrative Office, Seoul, Not set

Sanofi-Aventis Administrative Office, Beirut, Not set

Sanofi-Aventis Administrative Office, Col. Coyoacan, Not set

Sanofi-Aventis Administrative Office, Macquarie Park, Not set

Sanofi-Aventis Administrative Office, Warsaw, Not set

Sanofi-Aventis Administrative Office, Bucuresti, Not set

Sanofi-Aventis Administrative Office, Moscow, Not set

Sanofi-Aventis Administrative Office, Bratislava, Not set

Sanofi-Aventis Administrative Office, Ljubljana, Not set

Sanofi-Aventis Administrative Office, Gauteng, Not set

Sanofi-Aventis Administrative Office, Barcelona, Not set

Sanofi-Aventis Administrative Office, Bromma, Not set

Sanofi-Aventis Administrative Office, Genève, Not set

Sanofi-Aventis Administrative Office, Taipei, Not set

Sanofi-Aventis Administrative Office, Megrine, Not set

Sanofi-Aventis Administrative Office, Istanbul, Not set

Sanofi-Aventis Administrative Office, Guildford Surrey, Not set

Sanofi-Aventis Administrative Office, Montevideo, Not set

Sanofi-Aventis Administrative Office, Caracas, Not set

Conditions: Breast Neoplasms

Learn More ›

A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)

NCT00682981

Completed

The Phase I portion of this protocol will determine the best phase II dose and schedule of obatoclax with carboplatin and etoposide in patients with extensive-stage small cell lung cancer. The Phase II portion will evaluate the response rate to this regimen.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/19/2016

Locations: Clearview Cancer Institute, Huntsville, Alabama +74 locations

Clearview Cancer Institute, Huntsville, Alabama

Northwest Alabama Cancer Center, Muscle Shoals, Alabama

Mayo Clinic-Arizona, Scottsdale, Arizona

Arizona Clinical Research Center, Tucson, Arizona

City of Hope and Beckman Research Institute, Duarte, California

University of California-San Diego Moores Cancer Center, LaJolla, California

Georgetown University Hospital-Lombardi Comprehensive Cancer Center, Washington, District of Columbia

Integrated Community Oncology Network, Jacksonville, Florida

University of Miami-Sylvester Cancer Center, Miami, Florida

Florida Cancer Institute, New Port Richey, Florida

H. Lee Moffitt Cancer Center, Tampa, Florida

Northwest Georgia Oncology Centers, Marietta, Georgia

University of Chicago, Chicago, Illinois

Iowa Blood and Cancer Center, PLC, Cedar Rapids, Iowa

Cancer Center of Kansas, Wichita, Kansas

James Brown Cancer Center, Louisville, Kentucky

Center for Cancer and Blood Disorders, Bethesda, Maryland

Kalamazoo Hematology and Oncology, Kalamazoo, Michigan

Mid Ohio Oncology/Hematology, Inc., Columbus, Ohio

Cancer Care Associates-Oklahoma City, Oklahoma City, Oklahoma

Cancer Care Associates-Tulsa, Tulsa, Oklahoma

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania

Greater Philadelphia Cancer and Hematology Specialists, Philadelphia, Pennsylvania

Cancer Centers of the Carolinas, Greenville, South Carolina

McLeod Cancer & Blood Center, Johnson City, Tennessee

The West Clinic, Memphis, Tennessee

Baylor, Dallas, Texas

UT Southwestern Medical Center at Dallas, Dallas, Texas

Tyler Cancer Center, Tyler, Texas

Peninsula Cancer Institute, Newport News, Virginia

Virginia Oncology Associates, Norfolk, Virginia

Wheeling Hospital, Wheeling, West Virginia

MHAT "Dr. Tota Venkova", Gabrovo, Not set

District Dispensary for Cancer Diseases, Plovdiv, Plovdiv, Not set

District Dispensary for Oncology Diseases, Sofia City, Sofia, Not set

Specialized Hospital for Active Treatment in Oncology, Sofia, Not set

Tom Baker Cancer Centre, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

McGill University, Montreal, Quebec

Regional Hospital Kladno, Kladno, Not set

Hospital Kutna Hora, Kutna Hora, Not set

University Hospital Olomouc, Olomouc, Not set

Faculty Hospital Ostrava, Ostrava-Poruba, Not set

University Hospital Na Bulovce, Prague, Not set

National Institute of Tuberculosis & Pulmonology, Budapest, Not set

Semmelweis University Medical School, Budapest, Budapest, Not set

University Of Debrecen Medical and Health Science Centre, Debrecen, Not set

Csongrad County Council's Hospital for Chest Diseases, Deszk, Not set

Bacs-Kiskun County Hospital, Kecskemet, Not set

State Hospital Matrahaza, Matrahaza, Not set

Clinfan Ltd. SMO Tolna County Hospital, Szekszard, Not set

Pest County Hospital, Torokbalint, Not set

Vedanta Institute of Medical Sciences, Ahmedabad, Gujarat

Kailash Cancer Hospital and Research Centre, Goraj, Gujarat

Jawaharlal Nehru Cancer Hospital and Research Centre, Bhopal, Madhya Pradesh

Curie Manavata Cancer Centre, Nashik, Maharashtra

Noble Hospital, Pune, Maharashtra

Dr. Kamakshi Memorial Hospital, Chennai, Tamal Nadu

Galaxy Cancer Institute, Pushpanjali Crosslay Hospital, Ghaziabad, Uttar Pradesh

Orchid Nursing Home, Kolkata, West Bengal

Wojewodzki Szpital Specjalistyczny im. K. Dluskiego, Bialystok, Not set

SPZ Gruzlicy i Chorob Pluc, Olsztyn, Not set

Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy, Otwock, Not set

Specjalistyczny Szpital im Prof Alfreda Sokolowskiego, Szczecin-Zdunowo, Not set

Wojewodzki Szpital Chorob Pluc, Wodzislaw Slaski, Not set

Prof. Dr. Ion Chiricuta Oncology Institute Cluj Napoca, Cluj, Not set

Oncology Medical Centre SCM, Iasi, Not set

Emergency Clinical County Hospital Oradea, Oradea, Not set

Center for Pulmonary Diseases, Clinic for Internal Medicine, Kragujevac, Not set

Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Not set

Northern Ireland Cancer Centre Queens University Belfast, Belfast, Northern Ireland

Royal Bournemouth Hospital, Dorset, Not set

Nottingham University Hospital, Nottingham, Not set

Weston Park Hospital, Sheffield, Not set

Royal Surrey County Hospital, Surrey, Not set

Conditions: Extensive-stage Small Cell Lung Cancer

Learn More ›

Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer

NCT00686959

Completed

This study will compare the overall survival of participants with locally-advanced, Stage III Non-Small Cell Lung Cancer (NSCLC) with nonsquamous cell histology.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/20/2016

Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, Alabama +132 locations

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, Alabama

Conditions: Non Small Cell Lung Cancer

Learn More ›

Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer

NCT01666977

Completed

The purpose of this phase 1b/2 study is to estimate the treatment effect of study drug measuring progression free survival.

Gender:

ALL

Ages:

Between 18 years and 95 years

Trial Updated:

05/18/2016

Locations: Research Site, Fayetteville, Arkansas +34 locations

Research Site, Fayetteville, Arkansas

Research Site, Hot Springs, Arkansas

Research Site, Los Angeles, California

Research Site, Palm Springs, California

Research Site, Pleasant Hill, California

Research Site, San Diego, California

Research Site, Santa Monica, California

Research Site, Peoria, Illinois

Research Site, Paducah, Kentucky

Research Site, Hannover, New Hampshire

Research Site, Bronx, New York

Research Site, Bismarck, North Dakota

Research Site, Greenville, South Carolina

Research Site, Camperdown, New South Wales

Research Site, Kogarah, New South Wales

Research Site, Randwick, New South Wales

Research Site, Tweed Heads, New South Wales

Research Site, Herston, Queensland

Research Site, Bentleigh East, Victoria

Research Site, Heidelberg, Victoria

Research Site, Bruxelles, Not set

Research Site, Hamilton, Ontario

Research Site, Oshawa, Ontario

Research Site, Ottawa, Ontario

Research Site, Toronto, Ontario

Research Site, Laval, Quebec

Research Site, Levis, Quebec

Research Site, Montreal, Quebec

Research Site, Heraklion, Not set

Research Site, Larissa, Not set

Research Site, Patra, Not set

Research Site, Thessaloniki, Not set

Research Site, Málaga, Andalucía

Research Site, Zaragoza, Aragón

Research Site, Madrid, Not set

Conditions: Non Small Cell Lung Cancer

Learn More ›

A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer

NCT01239732

Completed

This open-label, non-comparative, multi-center study will assess the safety profile and efficacy of Avastin (bevacizumab) when added to carboplatin and paclitaxel therapy in participants with epithelial ovarian cancer, fallopian tube carcinoma or primary peritoneal carcinoma. Participants will receive 15 milligrams/kilogram (mg/kg) Avastin intravenously (IV) on Day 1 of every cycle for up to 36 cycles of 3 weeks each, carboplatin (area under the plasma concentration-time curve \[AUC\] 5-6 mg/ml/... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

05/03/2016

Locations: Not set, Buenos Aires, Not set +241 locations

Not set, Buenos Aires, Not set

Not set, Rosario, Not set

Not set, Tucuman, Not set

Not set, Graz, Not set

Not set, Innsbruck, Not set

Not set, Ried-innkreis, Not set

Not set, Salzburg, Not set

Not set, Steyr, Not set

Not set, Villach, Not set

Not set, Wien, Not set

Not set, Salvador, BA

Not set, Fortaleza, CE

Not set, Goiania, GO

Not set, Curitiba, PR

Not set, Rio de Janeiro, RJ

Not set, Porto Alegre, RS

Not set, Piracicaba, SP

Not set, Sao Paulo, SP

Not set, Sofia, Not set

Not set, Varna, Not set

Not set, Veliko Tarnovo, Not set

Not set, Calgary, Alberta

Not set, Ottawa, Ontario

Not set, Toronto, Ontario

Not set, Montreal, Quebec

Not set, Quebec, Not set

Not set, Aalborg, Not set

Not set, Roskilde, Not set

Not set, Vejle, Not set

Not set, Cairo, Not set

Not set, Tanta, Not set

Not set, Tallinn, Not set

Not set, Tartu, Not set

Not set, Amiens, Not set

Not set, Bordeaux, Not set

Not set, Brest, Not set

Not set, Caen, Not set

Not set, Clermont Ferrand, Not set

Not set, Grenoble, Not set

Not set, Lille, Not set

Not set, Lyon, Not set

Not set, Marseille, Not set

Not set, Mougins, Not set

Not set, Paris, Not set

Not set, Reims CEDEX, Not set

Not set, Strasbourg, Not set

Not set, Toulouse, Not set

Not set, Villejuif, Not set

Not set, Athens, Not set

Not set, Heraklion, Crete, Not set

Not set, Larissa, Not set

Not set, Patras, Not set

Not set, Thessaloniki, Not set

Not set, Hong Kong, Not set

Not set, Budapest, Not set

Not set, Debrecen, Not set

Not set, Pecs, Not set

Not set, Szeged, Not set

Not set, Bangalore, Not set

Not set, Hyderabad, Not set

Not set, Jaipur, Not set

Not set, Kochi, Not set

Not set, New Delhi, Not set

Not set, Pune, Not set

Not set, Dublin, Not set

Not set, Afula, Not set

Not set, Beer Sheva, Not set

Not set, Haifa, Not set

Not set, Holon, Not set

Not set, Jerusalem, Not set

Not set, Kfar Saba, Not set

Not set, Petach Tikva, Not set

Not set, Ramat Gan, Not set

Not set, Rehovot, Not set

Not set, Tel Aviv, Not set

Not set, Napoli, Campania

Not set, Bologna, Emilia-Romagna

Not set, Meldola, Emilia-Romagna

Not set, Roma, Lazio

Not set, Genova, Liguria

Not set, Brescia, Lombardia

Not set, Milano, Lombardia

Not set, Monza, Lombardia

Not set, Saronno, Lombardia

Not set, Novara, Piemonte

Not set, Torino, Piemonte

Not set, Palermo, Sicilia

Not set, Firenze, Toscana

Not set, Pisa, Toscana

Not set, Perugia, Umbria

Not set, Terni, Umbria

Not set, Shuwaikh, Not set

Not set, Daugavpils, Not set

Not set, Riga, Not set

Not set, Kaunas, Not set

Not set, Klaipeda, Not set

Not set, Vilnius, Not set

Not set, Bitola, Not set

Not set, Skopje, Not set

Not set, Distrito Federal, Not set

Not set, Oaxaca, Not set

Not set, Toluca, Not set

Not set, Alkmaar, Not set

Not set, Amsterdam, Not set

Not set, Apeldoorn, Not set

Not set, Blaricum, Not set

Not set, Breda, Not set

Not set, Capelle a/d IJssel, Not set

Not set, Den Haag, Not set

Not set, Deventer, Not set

Not set, Dordrecht, Not set

Not set, Eindhoven, Not set

Not set, Leidschendam, Not set

Not set, Rotterdam, Not set

Not set, Sittard-Geleen, Not set

Not set, Utrecht, Not set

Not set, Bydgoszcz, Not set

Not set, Warszawa, Not set

Not set, Porto, Not set

Not set, Bucuresti, Not set

Not set, Cluj Napoca, Not set

Not set, Iasi, Not set

Not set, Barnaul, Not set

Not set, Moscow, Not set

Not set, Obninsk, Kaluzhskaya Region, Not set

Not set, Saint-Petersburg, Not set

Not set, Stavropol, Not set

Not set, UFA, Not set

Not set, Dammam, Not set

Not set, Belgrade, Not set

Not set, Nis, Not set

Not set, Bratislava, Not set

Not set, Kosice, Not set

Not set, Ljubljana, Not set

Not set, Maribor, Not set

Not set, Durban, Not set

Not set, Johannesburg, Not set

Not set, Sandton, Not set

Not set, Elda, Alicante

Not set, Oviedo, Asturias

Not set, Llerena (Badajoz), Badajoz

Not set, Manresa, Barcelona

Not set, Cádiz, Cadiz

Not set, Jerez de La Frontera, Cadiz

Not set, San Sebastian de Los Reyes, Guipuzcoa

Not set, San Sebastian, Guipuzcoa

Not set, Palma De Mallorca, Islas Baleares

Not set, Palma de Mallorca, Islas Baleares

Not set, Santiago de Compostela, La Coruña

Not set, Las Palmas de Gran Canaria, Las Palmas

Not set, Leganes, Madrid

Not set, Reus, Tarragona

Not set, La Laguna, Tenerife

Not set, Santa Cruz de Tenerife, Tenerife

Not set, San Juan, Valencia

Not set, Barakaldo, Vizcaya

Not set, Bilbao, Vizcaya

Not set, Albacete, Not set

Not set, Alicante, Not set

Not set, Badajoz, Not set

Not set, Barcelona, Not set

Not set, Burgos, Not set

Not set, Caceres, Not set

Not set, Castellon, Not set

Not set, Ciudad Real, Not set

Not set, Cordoba, Not set

Not set, Girona, Not set

Not set, Granada, Not set

Not set, Guadalajara, Not set

Not set, Jaen, Not set

Not set, La Coruña, Not set

Not set, Lugo, Not set

Not set, Madrid, Not set

Not set, Malaga, Not set

Not set, Navarra, Not set

Not set, Salamanca, Not set

Not set, Segovia, Not set

Not set, Sevilla, Not set

Not set, Toledo, Not set

Not set, Valencia, Not set

Not set, Valladolid, Not set

Not set, Zaragoza, Not set

Not set, Eskilstuna, Not set

Not set, Falun, Not set

Not set, Karlstad, Not set

Not set, Umeå, Not set

Not set, Uppsala, Not set

Not set, Örebro, Not set

Not set, Aarau, Not set

Not set, Baden, Not set

Not set, Bellinzona, Not set

Not set, Bern, Not set

Not set, Genève 14, Not set

Not set, Zürich, Not set

Not set, Taipei City, Not set

Not set, Taoyuan Hsien, Not set

Not set, Ankara, Not set

Not set, Diyarbakir, Not set

Not set, Istanbul, Not set

Not set, Montevideo, Not set

Conditions: Ovarian Cancer

Learn More ›

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

NCT01082549

Completed

To evaluate the overall survival (OS) of patients with advanced squamous cell lung cancer receiving the combination of gemcitabine/carboplatin either with or without Iniparib. Based on data generated by BiPar/Sanofi, it is concluded that iniparib does not possess characteristics typical of the PARP inhibitor class. The exact mechanism has not yet been fully elucidated, however based on experiments on tumor cells performed in the laboratory, iniparib is a novel investigational anti-cancer agent... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/17/2016

Locations: Investigational Site Number 840306, Birmingham, Alabama +141 locations

Investigational Site Number 840306, Birmingham, Alabama

Investigational Site Number 840207, Huntsville, Alabama

Investigational Site Number 840351, Muscle Shoals, Alabama

Investigational Site Number 840338, Anaheim, California

Investigational Site Number 840353, Burbank, California

Investigational Site Number 840341, Concord, California

Investigational Site Number 840317, Duarte, California

Investigational Site Number 840339, La Verne, California

Investigational Site Number 840309, Loma Linda, California

Investigational Site Number 840307, Los Angeles, California

Investigational Site Number 840327, Maywood, California

Investigational Site Number 840303, San Diego, California

Investigational Site Number 840321, Santa Rosa, California

Investigational Site Number 840326, Stockton, California

Investigational Site Number 840310, Vallejo, California

Investigational Site Number 840336, Denver, Colorado

Investigational Site Number 840346, Norwich, Connecticut

Investigational Site Number 840315, Newark, Delaware

Investigational Site Number 840216, Ft. Lauderdale, Florida

Investigational Site Number 840215, Jacksonville, Florida

Investigational Site Number 840217, Lakeland, Florida

Investigational Site Number 840205, Orlando, Florida

Investigational Site Number 840104, Sarasota, Florida

Investigational Site Number 840343, Athens, Georgia

Investigational Site Number 840213, Augusta, Georgia

Investigational Site Number 840347, Augusta, Georgia

Investigational Site Number 840201, Gainesville, Georgia

Investigational Site Number 840301, Lawrenceville, Georgia

Investigational Site Number 840305, Marietta, Georgia

Investigational Site Number 840314, Tucker, Georgia

Investigational Site Number 840313, Chicago, Illinois

Investigational Site Number 840218, Evansville, Indiana

Investigational Site Number 840319, Indianapolis, Indiana

Investigational Site Number 840329, South Bend, Indiana

Investigational Site Number 840316, Wichita, Kansas

Investigational Site Number 840320, Louisville, Kentucky

Investigational Site Number 840308, Scarborough, Maine

Investigational Site Number 840202, Bethesda, Maryland

Investigational Site Number 840345, Salisbury, Maryland

Investigational Site Number 840337, Royal Oak, Michigan

Investigational Site Number 840328, St. Louis Park, Minnesota

Investigational Site Number 840210, Bridgeton, Missouri

Investigational Site Number 840212, Omaha, Nebraska

Investigational Site Number 840318, Las Vegas, Nevada

Investigational Site Number 840204, Morristown, New Jersey

Investigational Site Number 840350, Chapel Hill, North Carolina

Investigational Site Number 840330, Durham, North Carolina

Investigational Site Number 840105, Cincinnati, Ohio

Investigational Site Number 840302, Cleveland, Ohio

Investigational Site Number 840348, Cleveland, Ohio

Investigational Site Number 840335, Columbus, Ohio

Investigational Site Number 840311, Bend, Oregon

Investigational Site Number 840211, West Reading, Pennsylvania

Investigational Site Number 840352, Charleston, South Carolina

Investigational Site Number 840106, Columbia, South Carolina

Investigational Site Number 840220, Spartanburg, South Carolina

Investigational Site Number 840103, Chattanooga, Tennessee

Investigational Site Number 840208, Chattanooga, Tennessee

Investigational Site Number 840203, Collierville, Tennessee

Investigational Site Number 840101, Nashville, Tennessee

Investigational Site Number 840323, Fort Worth, Texas

Investigational Site Number 840219, Newport News, Virginia

Investigational Site Number 840102, Richmond, Virginia

Investigational Site Number 840312, Seattle, Washington

Investigational Site Number 840344, Tacoma, Washington

Investigational Site Number 840322, Morgantown, West Virginia

Investigational Site Number 840331, Wauwatosa, Wisconsin

Investigational Site Number 056004, Brugge, Not set

Investigational Site Number 056003, Brussel, Not set

Investigational Site Number 056001, Liège, Not set

Investigational Site Number 124003, Edmonton, Not set

Investigational Site Number 124006, Greenfield Park, Not set

Investigational Site Number 124005, London, Not set

Investigational Site Number 124007, Oshawa, Not set

Investigational Site Number 124004, Quebec, Not set

Investigational Site Number 124001, Toronto, Not set

Investigational Site Number 250007, Brest, Not set

Investigational Site Number 250002, Dijon, Not set

Investigational Site Number 250009, Limoges Cedex, Not set

Investigational Site Number 250003, Marseille, Not set

Investigational Site Number 250004, Paris Cedex 13, Not set

Investigational Site Number 250010, Pierre Benite Cedex, Not set

Investigational Site Number 250008, Poitiers, Not set

Investigational Site Number 250001, Saint-Herblain Cedex, Not set

Investigational Site Number 250006, Strasbourg, Not set

Investigational Site Number 250005, Tours Cedex 1, Not set

Investigational Site Number 276002, Amberg, Not set

Investigational Site Number 276004, Berlin, Not set

Investigational Site Number 276007, Frankfurt Am Main, Not set

Investigational Site Number 276008, Großhansdorf, Not set

Investigational Site Number 276010, Halle/Saale, Not set

Investigational Site Number 276012, Heidelberg, Not set

Investigational Site Number 276009, Immenhausen, Not set

Investigational Site Number 276001, Löwenstein, Not set

Investigational Site Number 276006, München, Not set

Investigational Site Number 276003, Oldenburg, Not set

Investigational Site Number 348005, Budapest, Not set

Investigational Site Number 348003, Budapest, Not set

Investigational Site Number 348001, Mátraháza, Not set

Investigational Site Number 348004, Nyíregyháza, Not set

Investigational Site Number 376002, Kfar Saba, Not set

Investigational Site Number 376005, Petah-Tikva, Not set

Investigational Site Number 376003, Tel Hashomer, Not set

Investigational Site Number 376001, Tzrifin, Not set

Investigational Site Number 380006, Genova, Not set

Investigational Site Number 380001, Novara, Not set

Investigational Site Number 380008, Orbassano, Not set

Investigational Site Number 380002, Perugia, Not set

Investigational Site Number 380003, Roma, Not set

Investigational Site Number 380007, Roma, Not set

Investigational Site Number 442001, Luxembourg, Not set

Investigational Site Number 528005, Breda, Not set

Investigational Site Number 528004, Eindhoven, Not set

Investigational Site Number 528001, Groningen, Not set

Investigational Site Number 528006, Maastricht, Not set

Investigational Site Number 528003, Zwolle, Not set

Investigational Site Number 616006, Bialystok, Not set

Investigational Site Number 616001, Krakow, Not set

Investigational Site Number 616007, Lubin, Not set

Investigational Site Number 616004, Olsztyn, Not set

Investigational Site Number 616008, Torun, Not set

Investigational Site Number 616002, Warszawa, Not set

Investigational Site Number 616005, Wroclaw, Not set

Investigational Site Number 642002, Alba Iulia, Not set

Investigational Site Number 642006, Bucuresti, Not set

Investigational Site Number 642001, Cluj Napoca, Not set

Investigational Site Number 642004, Craiova, Not set

Investigational Site Number 642005, Hunedoara, Not set

Investigational Site Number 724009, Badalona, Not set

Investigational Site Number 724003, Barcelona, Not set

Investigational Site Number 724004, La Coruña, Not set

Investigational Site Number 724005, Madrid, Not set

Investigational Site Number 724006, Madrid, Not set

Investigational Site Number 724002, Málaga, Not set

Investigational Site Number 724001, Palma De Mallorca, Not set

Investigational Site Number 724008, Sevilla, Not set

Investigational Site Number 724010, Valencia, Not set

Investigational Site Number 724007, Zaragoza, Not set

Investigational Site Number 826002, Glasgow, Not set

Investigational Site Number 826005, Leeds, Not set

Investigational Site Number 826001, Manchester, Not set

Investigational Site Number 826006, Wolverhampton, Not set

Conditions: Squamous Cell Lung Cancer

Learn More ›

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

NCT00130936

Terminated

Although declining in incidence, gastric/gastroesophageal cancer is still a commonly diagnosed malignancy in Canada. Patients who have undergone surgical resection for early disease have a high rate of local recurrence and distant spread. More than 50% of patients present with either locally advanced or metastatic disease. Patients with advanced disease have an extremely poor prognosis, with average survival times ranging from 3 - 9 months. Development of new therapeutic approaches for locally a... Read More

Gender:

ALL

Ages:

Between 18 years and 70 years

Trial Updated:

02/12/2016

Locations: Cross Cancer Institute, Edmonton, Alberta

Conditions: Gastric Cancer, Esophageal Cancer, Tumors

Learn More ›

Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy

NCT00006453

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if carboplatin is more effective with or without gemcitabine for ovarian epithelial cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of carboplatin with or without gemcitabine in treating patients who have advanced ovarian epithelial cancer that has not responded to previous che... Read More

Gender:

FEMALE

Ages:

Between 18 years and 120 years

Trial Updated:

12/22/2015

Locations: St. Mary's/Duluth Clinic Health System, Duluth, Minnesota +73 locations

St. Mary's/Duluth Clinic Health System, Duluth, Minnesota

Tom Baker Cancer Center - Calgary, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

Lethbridge Cancer Clinic, Lethbridge, Alberta

British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia

Nanaimo Cancer Clinic, Nanaimo, British Columbia

Penticton Regional Hospital, Penticton, British Columbia

British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey, British Columbia

Prostate Centre at Vancouver General Hospital, Vancouver, British Columbia

British Columbia Cancer Agency, Vancouver, British Columbia

St. Paul's Hospital - Vancouver, Vancouver, British Columbia

British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria, British Columbia

G. Steinhoff Clinical Research, Victoria, British Columbia

CancerCare Manitoba, Winnipeg, Manitoba

Moncton Hospital, Moncton, New Brunswick

Doctor Leon Richard Oncology Centre, Moncton, New Brunswick

Saint John Regional Hospital, Saint John, New Brunswick

Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador

Nova Scotia Cancer Centre, Halifax, Nova Scotia

Cape Breton Cancer Centre, Sydney, Nova Scotia

Royal Victoria Hospital, Barrie, Barrie, Ontario

William Osler Health Centre, Brampton, Ontario

Hamilton and Disrict Urology Association, Hamilton, Ontario

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario

Kingston Regional Cancer Centre, Kingston, Ontario

Grand River Regional Cancer Centre, Kitchner, Ontario

London Health Sciences Centre, London, Ontario

Cancer Care Ontario-London Regional Cancer Centre, London, Ontario

Markham Stouffville Hospital, Markham, Ontario

Trillium Health Centre, Mississauga, Ontario

Credit Valley Hospital, Mississauga, Ontario

York County Hospital, Newmarket, Ontario

North York General Hospital, Ontario, North York, Ontario

Male Health Centre/CMX Research Inc., Oakville, Ontario

Lakeridge Health Oshawa, Oshawa, Ontario

Ottawa Regional Cancer Centre, Ottawa, Ontario

Peterborough Oncology Clinic, Peterborough, Ontario

Algoma District Medical Group, Sault Sainte Marie, Ontario

Scarborough Hospital - General Site, Scarborough, Ontario

Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines, Ontario

Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario

Toronto East General Hospital, Toronto, Ontario

Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario

St. Michael's Hospital - Toronto, Toronto, Ontario

Mount Sinai Hospital - Toronto, Toronto, Ontario

Toronto General Hospital, Toronto, Ontario

Princess Margaret Hospital, Toronto, Ontario

Women's College Campus, Sunnybrook and Women's College Health Science Center, Toronto, Ontario

Saint Joseph's Health Centre - Toronto, Toronto, Ontario

Humber River Regional Hospital, Weston, Ontario

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor, Ontario

Queen Elizabeth Hospital, PEI, Charlottetown, Prince Edward Island

Complexe Hospitalier de la Sagamie, Chicoutimi, Quebec

CHUS-Hopital Fleurimont, Fleurimont, Quebec

Hopital Charles Lemoyne, Greenfield Park, Quebec

Centre Hospitalier Regional de Lanaudiere, Joliette, Quebec

L'Hotel Dieu de Levis, Levis, Quebec

Maisonneuve-Rosemont Hospital, Montreal, Quebec

Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec

McGill University, Montreal, Quebec

Centre Hospitalier de l'Universite' de Montreal, Montreal, Quebec

Hotel Dieu de Montreal, Montreal, Quebec

Hopital Sainte Justine, Montreal, Quebec

Hopital Du Sacre-Coeur de Montreal, Montreal, Quebec

Kells Medical Research Group Inc., Pointe Claire, Quebec

Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec

Hopital du Saint-Sacrament, Quebec, Quebec City, Quebec

Centre Hospitalier Regional de Rimouski, Rimouski, Quebec

L'Hopital Laval, Ste-Foy, Quebec

Allan Blair Cancer Centre, Regina, Saskatchewan

Saskatoon Cancer Centre, Saskatoon, Saskatchewan

Lions Gate Hospital, North Vancouver, Not set

Toronto Urology Study Group, Toronto, Not set

Conditions: Ovarian Cancer

Learn More ›

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

NCT00003273

Withdrawn

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of different regimens of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have newly diagnosed brain tumor.

Gender:

ALL

Ages:

10 years and below

Trial Updated:

11/30/2015

Locations: Cancer Research Center of Hawaii, Honolulu, Hawaii +18 locations

Conditions: Brain and Central Nervous System Tumors, Neuroblastoma, Retinoblastoma, Sarcoma

Learn More ›

Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer

NCT00003636

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining surgery with chemotherapy may kill more tumor cells. It is not yet known whether chemotherapy before surgery is more effective than chemotherapy after surgery in treating ovarian, peritoneal, or fallopian tube cancer. PURPOSE: This randomized phase III trial is studying chemotherapy given before surgery to see how well it works compared to chemotherapy given after su... Read More

Gender:

FEMALE

Ages:

All

Trial Updated:

08/04/2015

Locations: Hospital de Clinicas "Jose De San Martin", Buenos Aires, Not set +64 locations

Hospital de Clinicas "Jose De San Martin", Buenos Aires, Not set

Shaare Zedek Medical Center, Buenos Aires, Not set

Karl-Franzens-University Graz, Graz, Not set

Innsbruck Universitaetsklinik, Innsbruck, Not set

Allgemeines Krankenhaus - Universitatskliniken, Vienna, Not set

Ludwig Boltzmann Institute for Applied Cancer Research at Kaiser Franz Josef Hospital, Vienna, Not set

Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels, Not set

Universitair Ziekenhuis Antwerpen, Edegem, Not set

Cazk Groeninghe - Campus Maria's Voorzienigheid, Kortrijk, Not set

U.Z. Gasthuisberg, Leuven, Not set

Tom Baker Cancer Centre - Calgary, Calgary, Alberta

BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia

British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia

CancerCare Manitoba, Winnipeg, Manitoba

Saint John Regional Hospital, Saint John, New Brunswick

Doctor H. Bliss Murphy Cancer Centre, St. Johns, Newfoundland and Labrador

Nova Scotia Cancer Centre, Halifax, Nova Scotia

Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario

CHUS-Hopital Fleurimont, Fleurimont, Quebec

Hopital Charles Lemoyne, Greenfield Park, Quebec

McGill Cancer Centre at McGill University, Montreal, Quebec

Hopital Notre-Dame du CHUM, Montreal, Quebec

Herlev Hospital - University Hospital of Copenhagen, Copenhagen, Not set

Institut Bergonie, Bordeaux, Not set

Centre Oscar Lambret, Lille, Not set

Centre Hospitalier Regional et Universitaire de Lille, Lille, Not set

Institut Claudius Regaud, Toulouse, Not set

Martin Luther Universitaet, Halle, Not set

Coombe Women's Hospital, Dublin, Not set

St. James's Hospital, Dublin, Not set

Spedali Civili di Brescia, Brescia, Not set

Mirano General Hospital, Mirano-Venice, Not set

Libero Istituto Universitario Campus Bio-Medico, Rome, Not set

Azienda Sanitaria Ospedaliera Ordine Mauriziano, Torino, Not set

Clinica Universitaria, Turin, Not set

Vrije Universiteit Medisch Centrum, Amsterdam, Not set

Akademisch Ziekenhuis Vrije Universiteit - Medisch Centrum, Amsterdam, Not set

Onze Lieve Vrouwe Gasthuis, Amsterdam, Not set

Academisch Medisch Centrum at University of Amsterdam, Amsterdam, Not set

Leiden University Medical Center, Leiden, Not set

Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen, Not set

Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, Not set

Erasmus MC - Sophia Children's Hospital, Rotterdam, Not set

Haukeland Hospital - University of Bergen, Bergen, Not set

Norwegian Radium Hospital, Oslo, Not set

Hospitais da Universidade de Coimbra (HUC), Coimbra, Not set

Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A., Lisbon, Not set

Institut d'Oncologia Corachan, Barcelona, Not set

Hospital Universitario San Carlos, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario Central de Asturias, Oviedo, Not set

Lund University Hospital, Lund, Not set

Karolinska University Hospital - Huddinge, Stockholm, Not set

Umea Universitet, Umea, Not set

Uppsala University Hospital, Uppsala, Not set

Royal United Hospital, Bath, England

Cheltenham General Hospital, Cheltenham, England

University College of London Hospitals, London, England

Clatterbridge Centre for Oncology NHS Trust, Merseyside, England

James Cook University Hospital, Middlesbrough, England

Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood, England

Nottingham City Hospital NHS Trust, Nottingham, England

Staffordshire General Hospital, Stafford, England

Western Infirmary, Glasgow, Scotland

Queen Elizabeth The Queen Mother Hospital, Margate, Not set

Conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Learn More ›

High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas

NCT00078988

Completed

RATIONALE: Drugs used in chemotherapy, such as carboplatin, thiotepa, and etoposide, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with autologous stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. Isotretinoin may be effective in preventing recurrence of glioma. It is not yet known which regimen of chemotherapy plus autologous stem cell transplantation with or without... Read More

Gender:

ALL

Ages:

20 years and below

Trial Updated:

05/06/2015

Locations: Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas +58 locations

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas

Children's Hospital and Research Center - Oakland, Oakland, California

University of California Davis Cancer Center, Sacramento, California

Children's Hospital and Health Center - San Diego, San Diego, California

Children's Hospital Cancer Center, Denver, Colorado

Children's National Medical Center, Washington, District of Columbia

University of Florida Shands Cancer Center, Gainesville, Florida

Nemours Children's Clinic, Jacksonville, Florida

University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida

Miami Children's Hospital, Miami, Florida

All Children's Hospital, St. Petersburg, Florida

St. Joseph's Cancer Institute at St. Joseph's Hospital, Tampa, Florida

Kaplan Cancer Center at St. Mary's Medical Center, West Palm Beach, Florida

Emory University Hospital - Atlanta, Atlanta, Georgia

Cancer Research Center of Hawaii, Honolulu, Hawaii

Indiana University Cancer Center, Indianapolis, Indiana

St. Vincent Indianapolis Hospital, Indianapolis, Indiana

Kosair Children's Hospital, Louisville, Kentucky

CancerCare of Maine at Eastern Maine Medial Center, Bangor, Maine

Floating Hospital for Children at Tufts - New England Medical Center, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Spectrum Health Cancer Care - Butterworth Campus, Grand Rapids, Michigan

Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan

Children's Hospital of Minnesota - Minneapolis, Minneapolis, Minnesota

Fairview University Medical Center - University Campus, Minneapolis, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Children's Mercy Hospital, Kansas City, Missouri

Siteman Cancer Center at Barnes-Jewish Hospital, St. Louis, Missouri

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey

Roswell Park Cancer Institute, Buffalo, New York

NYU Cancer Institute at New York University Medical Center, New York, New York

Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York

SUNY Upstate Medical University Hospital, Syracuse, New York

New York Medical College, Valhalla, New York

Children's Hospital Medical Center of Akron, Akron, Ohio

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Rainbow Babies and Children's Hospital, Cleveland, Ohio

Columbus Children's Hospital, Columbus, Ohio

Children's Medical Center - Dayton, Dayton, Ohio

Oklahoma University Medical Center, Oklahoma City, Oklahoma

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania

Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina

Sioux Valley Hospital and University of South Dakota Medical Center, Sioux Falls, South Dakota

Cook Children's Medical Center - Fort Worth, Fort Worth, Texas

Covenant Children's Hospital, Lubbock, Texas

Primary Children's Medical Center, Salt Lake City, Utah

INOVA Fairfax Hospital, Fairfax, Virginia

Children's Hospital of the King's Daughters, Norfolk, Virginia

Massey Cancer Center at Virginia Commonwealth University, Richmond, Virginia

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin

Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin

Princess Margaret Hospital for Children, Perth, Western Australia

Children's & Women's Hospital of British Columbia, Vancouver, British Columbia

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario

Hospital for Sick Children, Toronto, Ontario

Montreal Children's Hospital at McGill University Health Center, Montreal, Quebec

Hopital Sainte Justine, Montreal, Quebec

Centre Hospitalier Universitaire de Quebec, Ste-Foy, Quebec

Conditions: Brain Tumor, Central Nervous System Tumor

Learn More ›

Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer

NCT00254891

Terminated

To assess the efficacy and safety of PF-3512676 administered in combination with paclitaxel/carboplatin chemotherapy as first-line treatment in patients with locally advanced or metastatic Non-Small-Cell Lung Cancer (NSCLC) and to compare it to the efficacy and safety of paclitaxel

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/10/2015

Locations: Pfizer Investigational Site, Little Rock, Alaska +190 locations

Pfizer Investigational Site, Little Rock, Alaska

Pfizer Investigational Site, Hot Springs, Arkansas

Pfizer Investigational Site, Chula Vista, California

Pfizer Investigational Site, La Mesa, California

Pfizer Investigational Site, Oceanside, California

Pfizer Investigational Site, Palm Springs, California

Pfizer Investigational Site, San Diego, California

Pfizer Investigational Site, San Francisco, California

Pfizer Investigational Site, Atlanta, Georgia

Pfizer Investigational Site, Decatur, Georgia

Pfizer Investigational Site, Fayetteville, Georgia

Pfizer Investigational Site, Macon, Georgia

Pfizer Investigational Site, Marietta, Georgia

Pfizer Investigational Site, Tucker, Georgia

Pfizer Investigational Site, Rockford, Illinois

Pfizer Investigational Site, Jefferson, Indiana

Pfizer Investigational Site, New Albany, Indiana

Pfizer Investigational Site, Cedar Rapids, Iowa

Pfizer Investigational Site, Dubuque, Iowa

Pfizer Investigational Site, Lexington, Kentucky

Pfizer Investigational Site, Louisville, Kentucky

Pfizer Investigational Site, Shelbyville, Kentucky

Pfizer Investigational Site, Covington, Louisiana

Pfizer Investigational Site, Gretna, Louisiana

Pfizer Investigational Site, Lafayette, Louisiana

Pfizer Investigational Site, Marrero, Louisiana

Pfizer Investigational Site, Metairie, Louisiana

Pfizer Investigational Site, New Orleans, Louisiana

Pfizer Investigational Site, Biddeford, Maine

Pfizer Investigational Site, Brunswick, Maine

Pfizer Investigational Site, Scarborough, Maine

Pfizer Investigational Site, Worcester, Massachusetts

Pfizer Investigational Site, Allegan, Michigan

Pfizer Investigational Site, Ann Arbor, Michigan

Pfizer Investigational Site, Kalamazoo, Michigan

Pfizer Investigational Site, St. Joseph, Michigan

Pfizer Investigational Site, Columbus, Mississippi

Pfizer Investigational Site, Corinth, Mississippi

Pfizer Investigational Site, Tupelo, Mississippi

Pfizer Investigational Site, Omaha, Nebraska

Pfizer Investigational Site, Papillion, Nebraska

Pfizer Investigational Site, Las Vegas, Nevada

Pfizer Investigational Site, Albuquerque, New Mexico

Pfizer Investigational Site, Ruidoso, New Mexico

Pfizer Investigational Site, Buffalo, New York

Pfizer Investigational Site, Great Neck, New York

Pfizer Investigational Site, Asheville, North Carolina

Pfizer Investigational Site, Brevard, North Carolina

Pfizer Investigational Site, Lexington, North Carolina

Pfizer Investigational Site, Winston-Salem, North Carolina

Pfizer Investigational Site, Canton, Ohio

Pfizer Investigational Site, Dover, Ohio

Pfizer Investigational Site, Oklahoma City, Oklahoma

Pfizer Investigational Site, Portland, Oregon

Pfizer Investigational Site, Langhorne, Pennsylvania

Pfizer Investigational Site, Chattanooga, Tennessee

Pfizer Investigational Site, Memphis, Tennessee

Pfizer Investigational Site, Arlington, Texas

Pfizer Investigational Site, Dallas, Texas

Pfizer Investigational Site, Richardson, Texas

Pfizer Investigational Site, Trophy Club, Texas

Pfizer Investigational Site, Bountiful, Utah

Pfizer Investigational Site, Layton, Utah

Pfizer Investigational Site, Murray, Utah

Pfizer Investigational Site, Provo, Utah

Pfizer Investigational Site, Salt Lake City, Utah

Pfizer Investigational Site, WVC, Utah

Pfizer Investigational Site, Burlington, Vermont

Pfizer Investigational Site, Everett, Washington

Pfizer Investigational Site, Kennewick, Washington

Pfizer Investigational Site, Richland, Washington

Pfizer Investigational Site, Madison, Wisconsin

Pfizer Investigational Site, Albury, New South Wales

Pfizer Investigational Site, Camperdown, New South Wales

Pfizer Investigational Site, Randwick, New South Wales

Pfizer Investigational Site, Pimlico, Queensland

Pfizer Investigational Site, Townsville, Queensland

Pfizer Investigational Site, Woolloongabba, Queensland

Pfizer Investigational Site, Bedford Park, South Australia

Pfizer Investigational Site, Toorak Gardens, South Australia

Pfizer Investigational Site, East Melbourne, Victoria

Pfizer Investigational Site, East Ringwood, Victoria

Pfizer Investigational Site, Wodonga, Victoria

Pfizer Investigational Site, Nedlands, Western Australia

Pfizer Investigational Site, Gent, Not set

Pfizer Investigational Site, Liège, Not set

Pfizer Investigational Site, Moncton, New Brunswick

Pfizer Investigational Site, Montreal, Quebec

Pfizer Investigational Site, Rimouski, Quebec

Pfizer Investigational Site, Saskatoon, Saskatchewan

Pfizer Investigational Site, Dalian, Xigang District, Liaoning

Pfizer Investigational Site, Beijing, Not set

Pfizer Investigational Site, Shanghai, Not set

Pfizer Investigational Site, Nicosia, Not set

Pfizer Investigational Site, Nova Ves Pod Plesi, Not set

Pfizer Investigational Site, Ostrava-Poruba, Not set

Pfizer Investigational Site, Usti nad Labem, Not set

Pfizer Investigational Site, Angers cedex, Not set

Pfizer Investigational Site, Caen cedex, Not set

Pfizer Investigational Site, Dijon, Not set

Pfizer Investigational Site, Limoges, Not set

Pfizer Investigational Site, Nantes Cedex 2, Not set

Pfizer Investigational Site, Paris Cedex 13, Not set

Pfizer Investigational Site, St Herblain Cedex, Not set

Pfizer Investigational Site, Strasbourg, Not set

Pfizer Investigational Site, Toulouse cedex 9, Not set

Pfizer Investigational Site, Vandoeuvre Les Nancy, Not set

Pfizer Investigational Site, Berlin, Not set

Pfizer Investigational Site, Bielefeld, Not set

Pfizer Investigational Site, Bonn, Not set

Pfizer Investigational Site, Essen, Not set

Pfizer Investigational Site, Frankfurt, Not set

Pfizer Investigational Site, Karlsruhe, Not set

Pfizer Investigational Site, Muenchen, Not set

Pfizer Investigational Site, Athens, Attica

Pfizer Investigational Site, Heraklion, Crete

Pfizer Investigational Site, Thessaloniki, Macedonia

Pfizer Investigational Site, Athens, Not set

Pfizer Investigational Site, Rio, Patras, Not set

Pfizer Investigational Site, Pokfulam, Not set

Pfizer Investigational Site, Budapest, Not set

Pfizer Investigational Site, Debrecen, Not set

Pfizer Investigational Site, Bangalore, Karnataka

Pfizer Investigational Site, Kochi, Kerala

Pfizer Investigational Site, Pune, Maharashtra

Pfizer Investigational Site, Chandigarh, Punjab

Pfizer Investigational Site, Jaipur, Rajasthan

Pfizer Investigational Site, Zerifin, Not set

Pfizer Investigational Site, Lido di Camaiore (LU), Not set

Pfizer Investigational Site, Milano, Not set

Pfizer Investigational Site, Napoli, Not set

Pfizer Investigational Site, Pavia, Not set

Pfizer Investigational Site, Seoul, Not set

Pfizer Investigational Site, Mexico, DF

Pfizer Investigational Site, Puebla, Not set

Pfizer Investigational Site, Tiel, GLD

Pfizer Investigational Site, Groningen, GR

Pfizer Investigational Site, Amstelveen, Not set

Pfizer Investigational Site, Den Haag, Not set

Pfizer Investigational Site, Otwock, Not set

Pfizer Investigational Site, Wodzislaw Sl., Not set

Pfizer Investigational Site, Faro, Not set

Pfizer Investigational Site, Porto, Not set

Pfizer Investigational Site, Vila Nova de Gaia, Not set

Pfizer Investigational Site, Parktown, Gauteng

Pfizer Investigational Site, Cape Town, Not set

Pfizer Investigational Site, Johannesburg, Not set

Pfizer Investigational Site, Badalona, Barcelona

Pfizer Investigational Site, Alcorcon, Madrid

Pfizer Investigational Site, Pamplona, Navarra

Pfizer Investigational Site, Madrid, Not set

Pfizer Investigational Site, Santa Cruz de Tenerife, Not set

Pfizer Investigational Site, Valencia, Not set

Pfizer Investigational Site, Stockholm, Not set

Pfizer Investigational Site, Uppsala, Not set

Pfizer Investigational Site, Lausanne, Not set

Pfizer Investigational Site, Taipei, Not set

Pfizer Investigational Site, Truro, Cornwall

Pfizer Investigational Site, Exeter, Devon

Pfizer Investigational Site, London, Not set

Pfizer Investigational Site, Portsmouth, Not set

Pfizer Investigational Site, Sheffield, Not set

Pfizer Investigational Site, Surrey GU2 5XX, Not set

Pfizer Investigational Site, Swansea, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›